Search Results

You are looking at 1 - 10 of 40 items for :

  • "Pancreas cancer" x
  • Refine by Access: All x
Clear All
Full access

Andrew S. Epstein and Eileen M. O'Reilly

are a major contributor to cancer- and treatment-related morbidity and mortality. Exocrine pancreas cancer is one of the most common malignancies associated with thrombosis, with most modern studies reporting incidence ranging from 5% to 27%. 1 – 6

Full access

Mary F. Mulcahy, Andrew O. Wahl, and William Small Jr.

HA 3rd Moore MJ Anderson J . Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial . J Clin Oncol 1997 ; 15 : 2403 – 2413 . 3 Neoptolemos JP

Full access

Kamel Izeradjene and Sunil R. Hingorani

gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial . J Clin Oncol 1997 ; 15 : 2403 – 2413 . 4. Allison DC Piantadosi S Hruban RH . DNA content and other factors associated with ten-year survival

Full access

Stuart A. Grossman, Susannah Ellsworth, Jian Campian, Aaron T. Wild, Joseph M. Herman, Dan Laheru, Malcolm Brock, Ani Balmanoukian, and Xiaobu Ye

pancreas cancer; (C) unresected pancreas cancer; and (D) non–small cell lung cancer. Table 3 Relationships Between Survival and Grade III/IV Treatment-Related Lymphopenia were controlled for, a relationship between TRL and survival was

Full access

Bin Wu and Lizheng Shi

Pancreas Cancer Olaparib Ongoing (POLO) trial reported the efficacy and safety of maintenance olaparib compared with placebo in patients with MPC with a germline BRCA mutation. 8 Results revealed that maintenance olaparib notably prolonged median

Full access

/7/13 Liver-Directed Therapies in Patients With Advanced Neuroendocrine Tumors Expiration Date: 6/4/13 Exocrine Pancreas Cancer and Thromboembolic Events: A Systematic Literature Review Expiration Date: 7/7/13 Monitoring Minimal Residual Disease in

Full access

/4/13 Exocrine Pancreas Cancer and Thromboembolic Events: A Systematic Literature Review Expiration Date: 7/7/13 Monitoring Minimal Residual Disease in Acute Myeloid Leukemia: Ready for Prime Time? Expiration Date: 8/7/13 Androgen Deprivation Therapy

Full access

CME/CE articles published in previous issues of JNCCN: Exocrine Pancreas Cancer and Thromboembolic Events: A Systematic Literature Review Expiration Date: 7/7/13 Monitoring Minimal Residual Disease in Acute Myeloid Leukemia: Ready

Full access

Alok A. Khorana

discussion of this is the subject of my article 4 and beyond the scope of this response. I would like, however, to illustrate this struggle by pointing out that in a randomized clinical trial of prophylaxis in patients with pancreas cancer, VTE during

Full access

Andrew D. Boyd and Michelle Riba

Thaler HT . Pain and depression in patients with newly diagnosed pancreas cancer . J Clin Oncol 1995 ; 13 : 748 – 755 . 15. Passik SD Roth AJ . Anxiety symptoms and panic attacks preceding pancreatic cancer diagnosis . Psychooncology